Total Knee Arthroplasty after Gene Therapy for Hemophilia B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Total Knee Arthroplasty after Gene Therapy for Hemophilia B

Published:2022-10-27 Issue:17 Volume:387 Page:1622-1624
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Xue Feng¹,Wang PanJing²,Yuan Zhen,Shi Chao,Fang Yunhai³,Liu Wei,Wang Yuhua,Xiao Xiao⁴,Yang Renchi⁵,George Lindsey A.⁶,Zhang Lei¹

Affiliation:

1. State Key Laboratory of Experimental Hematology, Tianjin, China

2. Peking Union Medical College, Beijing, China

3. Shandong Blood Center, Jinan, China

4. Belief BioMed, Shanghai, China

5. Blood Diseases Hospital, Tianjin, China

6. University of Pennsylvania School of Medicine, Philadelphia, PA

Funder

the National Key Research and Development Program of China

Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences

CAMS Innovation Fund for Medical Sciences

Bayer Hemophilia Award Program

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc2211173

Reference4 articles.

1. The role of total ankle replacement in patients with haemophilia and end‐stage ankle arthropathy: A review

2. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant

3. Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial

4. Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report on the diagnosis and treatment of hemophilia in China (Version 2024);LabMed Discovery;2024-07

2. Perioperative Management of Hemophilia Patients;Current Anesthesiology Reports;2024-06-14

3. China’s top 10 achievements in hematology in 2022;Blood Science;2023-03-27

4. Big stride in gene therapy for hemophilia B in China;Blood Science;2023-01-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3